MEVIS MEDICAL SOLUTIONS AG (M3V.DE) Stock Income Statement
FRA:M3V - Deutsche Boerse Ag - DE000A0LBFE4 - Common Stock - Currency: EUR
| 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 16.97M | 17.34M | 18.76M | 16.21M | 17.13M | |||
| Cost Of Goods | 490.00K | 445.00K | 747.00K | 437.00K | 626.00K | |||
| Gross Profit | 16.48M | 16.90M | 18.02M | 15.78M | 16.50M | |||
| Operating Expenses | 12.48M | 11.99M | 11.54M | 11.36M | 10.63M | |||
| Selling, General, and Administrative Expenses | 11.05M | 10.54M | 10.42M | 10.70M | 9.73M | |||
| Operating Income | 4.00M | 4.91M | 6.47M | 4.42M | 5.87M | |||
| Interest Income/Expense | 705.00K | 172.00K | 1.41M | 223.00K | -65.00K | |||
| Other Income/Expense | -20.00K | -43.00K | -4.00K | -11.00K | -12.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | 4.69M | 5.03M | 7.88M | 4.63M | 5.79M | |||
| Income Tax | 126.00K | 114.00K | 87.00K | 85.00K | 90.00K | |||
| Net Income | 4.56M | 4.92M | 7.79M | 4.55M | 5.70M | |||
| EBITDA | 4.13M | 5.00M | 6.56M | 4.54M | 6.04M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.51 | 2.70 | 4.28 | 2.50 | 3.13 | |||
| Statistics | ||||||||
| Gross Profit Margin | 97.11% | 97.43% | 96.02% | 97.30% | 96.35% | |||
| Profit Margin | 26.87% | 28.37% | 41.51% | 28.04% | 33.30% | |||
| Operating Profit Margin | 23.58% | 28.28% | 34.48% | 27.25% | 34.27% | |||
All data in EUR